Jeff Breslin Serves As The Honorary Chairman for the Cystic Fibrosis Foundation’s 2014 Maryland’s Finest Event

IMMEDIATE RELEASE

Baltimore, Maryland- The Maryland Chapter of the Cystic Fibrosis (CF) Foundation names Jeff Breslin as the honorary chair of the 2014 Maryland’s Finest event. This event honors young professionals who show great promise and leadership, and serve as ambassadors for the Foundation, through advocacy and fundraising efforts. The collective fundraising goal for this event is $150,000, to support the Foundation’s research and patient support programs. The Maryland’s Finest awards ceremony will be held on November 13, 2014 at the Maryland Science Center, recognizing this year’s honorees.

Jeff Breslin, 30, is a graduate of York College and the Vice President of Programs for the Cal Ripken Sr. Foundation. In his role with the Cal Ripken Sr. Foundation, Jeff oversees all grants and programmatic initiatives impacting at risk youth nationwide. He is also an active member of the Maryland Chapter of the Cystic Fibrosis Foundation- Board of Directors. Jeff was the top fundraiser for the 2013 Extreme Hike. Through his continual involvement in CF Foundation events, and dedication to mentoring youth through sports, Jeff is an excellent role model for other young professionals. Jeff was diagnosed with Cystic Fibrosis as a child, but has refused to let the disease limit his ambitions and aspirations. On a daily basis, he transforms his challenges with CF, into an opportunity to encourage and help others live to their fullest potential. “I couldn’t be more proud to serve as the honorary chair for the 2014 Maryland’s Finest event, benefiting the Cystic Fibrosis Foundation. I’m looking forward to working with so many talented Marylanders, as we all strive to ensure ‘CF’ stands for ‘Cure Found’ very soon,” says Jeff. For more information about Jeff Breslin, please visit: https://www.youtube.com/watch?v=lQ_xVgHPUEg.

The Cystic Fibrosis Foundation is the world’s leader in the search for a cure for CF. CF is a life-threatening, inherited chronic disease that obstructs the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). Currently, the Foundations efforts have produced drug therapies that have increased the life expectancy for CF patients from 5 years of age to over 40 years of age. Much of the Foundation’s effectiveness in fighting CF can be attributed to its efficient use of charitable funding. Over 90% of every dollar raised supports CF research, patient/family care, and education programs. The Foundation’s drug development success has been recognized by Harvard Business School and by publications such as Forbes, Discover magazine, and The Wall Street Journal. For more information about the Maryland Chapter of Cystic Fibrosis Foundation and Maryland’s Finest, please visit: maryland.cff.org.

###